1Huben RP.Tumor markers in bladder cancer.Urology,1984,23(3):10-14.
2Schroeder GL,Lorenzo-Gomez MF,Hautmann SH,et al.A side by side comparison of cytology and biomarkers for bladder cancer detection.J Urol,2004,172(3):1123-1126.
3Kikuchi H.Tumor markers of urinary tract carcinoma.Rinsho Byori,2004,52(4):371-380.
4Chartier-Kastler EJ, Ruud-Bosch JL, Perrigot M,et al.Long-term results of sacral nerve stimulation (S3) for the treatment of neurogenic refractory urge incontinence related to detrusor hyperreflexia.J Urol,2000,164(5):1476-1480.
5Sheinfeld J,Reuter VE,Melamed MR,et a1.Enhanced bladder cancer detection with the Lewis x antigen as a marker of neoplastic transformation.J Urol,1990,143(2):285-288.
6Sjakste N,Sjakste T,Vikmanis U.Role of the nuclear matrix proteins in malignant transformation and cancer diagnosis.Exp Oncol,2004,26(3):170-178.
8Yokoyama T,Sekigawa R,Hayashi T,et al.The clinical efficacy of Bladder Chek NMP22 in urothelial cancer.Rinsho Byori,2004,52(3):199-203.
9Konety BR,Nguyen TS,Brenes G,et al.Clinical usefulness of the novel marker BLCA-4 for the detection of bladder cancer.J Urol,2000,164(3):634-639.
10Moses MA,Wiederschain D,Loughlin KR,et al.Increased incidence of matrix metalloproteinases in urine of cancer patients.Cancer Res,1998,58(7):1395-1399.
